LIVE: 'This is why we don't believe you' — Congress rails on the maker of EpiPen

September 21, 2016 7:52 PM

1 0

Heather Bresch, the CEO of Mylan — which makes the EpiPen — is testifying in front of the House Oversight and Government Reform Committee about the drug's price after an hour-long delay.

The price of the device, used in emergencies to treat severe allergic reactions, has increased more than 500% since Mylan acquired it in 2007. A two-pack of the EpiPen now has a list price of $608.

Read more

To category page